001     269348
005     20260212164259.0
024 7 _ |2 doi
|a 10.1038/s41380-023-02149-1
024 7 _ |2 pmid
|a pmid:37433967
024 7 _ |2 pmc
|a pmc:PMC11041653
024 7 _ |2 ISSN
|a 1359-4184
024 7 _ |2 ISSN
|a 1476-5578
024 7 _ |2 altmetric
|a altmetric:151223266
037 _ _ |a DZNE-2024-00517
041 _ _ |a English
082 _ _ |a 610
100 1 _ |0 0000-0002-7940-0335
|a Amare, Azmeraw T
|b 0
245 _ _ |a Association of polygenic score and the involvement of cholinergic and glutamatergic pathways with lithium treatment response in patients with bipolar disorder.
260 _ _ |a London
|b Macmillan
|c 2023
336 7 _ |2 DRIVER
|a article
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
|s 1715674675_2123
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
336 7 _ |0 0
|2 EndNote
|a Journal Article
520 _ _ |a Lithium is regarded as the first-line treatment for bipolar disorder (BD), a severe and disabling mental health disorder that affects about 1% of the population worldwide. Nevertheless, lithium is not consistently effective, with only 30% of patients showing a favorable response to treatment. To provide personalized treatment options for bipolar patients, it is essential to identify prediction biomarkers such as polygenic scores. In this study, we developed a polygenic score for lithium treatment response (Li+PGS) in patients with BD. To gain further insights into lithium's possible molecular mechanism of action, we performed a genome-wide gene-based analysis. Using polygenic score modeling, via methods incorporating Bayesian regression and continuous shrinkage priors, Li+PGS was developed in the International Consortium of Lithium Genetics cohort (ConLi+Gen: N = 2367) and replicated in the combined PsyCourse (N = 89) and BipoLife (N = 102) studies. The associations of Li+PGS and lithium treatment response - defined in a continuous ALDA scale and a categorical outcome (good response vs. poor response) were tested using regression models, each adjusted for the covariates: age, sex, and the first four genetic principal components. Statistical significance was determined at P < 0.05. Li+PGS was positively associated with lithium treatment response in the ConLi+Gen cohort, in both the categorical (P = 9.8 × 10-12, R2 = 1.9%) and continuous (P = 6.4 × 10-9, R2 = 2.6%) outcomes. Compared to bipolar patients in the 1st decile of the risk distribution, individuals in the 10th decile had 3.47-fold (95%CI: 2.22-5.47) higher odds of responding favorably to lithium. The results were replicated in the independent cohorts for the categorical treatment outcome (P = 3.9 × 10-4, R2 = 0.9%), but not for the continuous outcome (P = 0.13). Gene-based analyses revealed 36 candidate genes that are enriched in biological pathways controlled by glutamate and acetylcholine. Li+PGS may be useful in the development of pharmacogenomic testing strategies by enabling a classification of bipolar patients according to their response to treatment.
536 _ _ |0 G:(DE-HGF)POF4-353
|a 353 - Clinical and Health Care Research (POF4-353)
|c POF4-353
|f POF IV
|x 0
536 _ _ |0 G:(DE-HGF)POF4-352
|a 352 - Disease Mechanisms (POF4-352)
|c POF4-352
|f POF IV
|x 1
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |0 9FN79X2M3F
|2 NLM Chemicals
|a Lithium
650 _ 7 |0 3KX376GY7L
|2 NLM Chemicals
|a Glutamic Acid
650 _ 7 |2 NLM Chemicals
|a Lithium Compounds
650 _ 7 |0 N9YNS0M02X
|2 NLM Chemicals
|a Acetylcholine
650 _ 7 |2 NLM Chemicals
|a Antimanic Agents
650 _ 2 |2 MeSH
|a Bipolar Disorder: drug therapy
650 _ 2 |2 MeSH
|a Bipolar Disorder: genetics
650 _ 2 |2 MeSH
|a Humans
650 _ 2 |2 MeSH
|a Female
650 _ 2 |2 MeSH
|a Male
650 _ 2 |2 MeSH
|a Multifactorial Inheritance: genetics
650 _ 2 |2 MeSH
|a Adult
650 _ 2 |2 MeSH
|a Middle Aged
650 _ 2 |2 MeSH
|a Lithium: therapeutic use
650 _ 2 |2 MeSH
|a Lithium: pharmacology
650 _ 2 |2 MeSH
|a Treatment Outcome
650 _ 2 |2 MeSH
|a Bayes Theorem
650 _ 2 |2 MeSH
|a Genome-Wide Association Study: methods
650 _ 2 |2 MeSH
|a Glutamic Acid: metabolism
650 _ 2 |2 MeSH
|a Cohort Studies
650 _ 2 |2 MeSH
|a Lithium Compounds: therapeutic use
650 _ 2 |2 MeSH
|a Lithium Compounds: pharmacology
650 _ 2 |2 MeSH
|a Acetylcholine: metabolism
650 _ 2 |2 MeSH
|a Polymorphism, Single Nucleotide: genetics
650 _ 2 |2 MeSH
|a Antimanic Agents: therapeutic use
650 _ 2 |2 MeSH
|a Antimanic Agents: pharmacology
700 1 _ |a Thalamuthu, Anbupalam
|b 1
700 1 _ |0 0000-0003-1690-0209
|a Schubert, Klaus Oliver
|b 2
700 1 _ |0 0000-0003-4014-4490
|a Fullerton, Janice M
|b 3
700 1 _ |a Ahmed, Muktar
|b 4
700 1 _ |0 0000-0001-9689-0594
|a Hartmann, Simon
|b 5
700 1 _ |0 0000-0001-9366-8728
|a Papiol, Sergi
|b 6
700 1 _ |0 P:(DE-2719)9000977
|a Heilbronner, Urs
|b 7
700 1 _ |a Degenhardt, Franziska
|b 8
700 1 _ |a Tekola-Ayele, Fasil
|b 9
700 1 _ |a Hou, Liping
|b 10
700 1 _ |a Hsu, Yi-Hsiang
|b 11
700 1 _ |a Shekhtman, Tatyana
|b 12
700 1 _ |a Adli, Mazda
|b 13
700 1 _ |a Akula, Nirmala
|b 14
700 1 _ |a Akiyama, Kazufumi
|b 15
700 1 _ |a Ardau, Raffaella
|b 16
700 1 _ |0 0000-0001-9181-2132
|a Arias, Bárbara
|b 17
700 1 _ |a Aubry, Jean-Michel
|b 18
700 1 _ |a Hasler, Roland
|b 19
700 1 _ |a Richard-Lepouriel, Hélène
|b 20
700 1 _ |a Perroud, Nader
|b 21
700 1 _ |a Backlund, Lena
|b 22
700 1 _ |a Bhattacharjee, Abesh Kumar
|b 23
700 1 _ |a Bellivier, Frank
|b 24
700 1 _ |a Benabarre, Antonio
|b 25
700 1 _ |a Bengesser, Susanne
|b 26
700 1 _ |0 0000-0001-9350-4440
|a Biernacka, Joanna M
|b 27
700 1 _ |a Birner, Armin
|b 28
700 1 _ |0 0000-0002-2282-134X
|a Marie-Claire, Cynthia
|b 29
700 1 _ |a Cervantes, Pablo
|b 30
700 1 _ |0 0000-0003-3191-0093
|a Chen, Hsi-Chung
|b 31
700 1 _ |a Chillotti, Caterina
|b 32
700 1 _ |0 0000-0002-9475-086X
|a Cichon, Sven
|b 33
700 1 _ |0 0000-0002-7799-5531
|a Cruceanu, Cristiana
|b 34
700 1 _ |0 0000-0003-0745-5916
|a Czerski, Piotr M
|b 35
700 1 _ |a Dalkner, Nina
|b 36
700 1 _ |0 0000-0001-9491-5938
|a Del Zompo, Maria
|b 37
700 1 _ |0 0000-0001-9221-9226
|a DePaulo, J Raymond
|b 38
700 1 _ |0 0000-0002-5377-1488
|a Étain, Bruno
|b 39
700 1 _ |0 0000-0002-4321-4100
|a Jamain, Stephane
|b 40
700 1 _ |a Falkai, Peter
|b 41
700 1 _ |0 0000-0002-1876-6368
|a Forstner, Andreas J
|b 42
700 1 _ |a Frisen, Louise
|b 43
700 1 _ |0 0000-0001-6997-4215
|a Frye, Mark A
|b 44
700 1 _ |a Gard, Sébastien
|b 45
700 1 _ |0 0000-0002-7987-4995
|a Garnham, Julie S
|b 46
700 1 _ |0 0000-0001-6262-8264
|a Goes, Fernando S
|b 47
700 1 _ |0 0000-0002-1304-6687
|a Grigoroiu-Serbanescu, Maria
|b 48
700 1 _ |0 P:(DE-2719)2811701
|a Fallgatter, Andreas
|b 49
|u dzne
700 1 _ |a Stegmaier, Sophia
|b 50
700 1 _ |a Ethofer, Thomas
|b 51
700 1 _ |a Biere, Silvia
|b 52
700 1 _ |a Petrova, Kristiyana
|b 53
700 1 _ |a Schuster, Ceylan
|b 54
700 1 _ |a Adorjan, Kristina
|b 55
700 1 _ |a Budde, Monika
|b 56
700 1 _ |a Heilbronner, Maria
|b 57
700 1 _ |0 0000-0003-0930-4214
|a Kalman, Janos L
|b 58
700 1 _ |0 0000-0002-1357-2636
|a Kohshour, Mojtaba Oraki
|b 59
700 1 _ |a Reich-Erkelenz, Daniela
|b 60
700 1 _ |a Schaupp, Sabrina K
|b 61
700 1 _ |0 0000-0003-3105-5672
|a Schulte, Eva C
|b 62
700 1 _ |a Senner, Fanny
|b 63
700 1 _ |a Vogl, Thomas
|b 64
700 1 _ |a Anghelescu, Ion-George
|b 65
700 1 _ |a Arolt, Volker
|b 66
700 1 _ |a Dannlowski, Udo
|b 67
700 1 _ |a Dietrich, Detlef
|b 68
700 1 _ |a Figge, Christian
|b 69
700 1 _ |a Jäger, Markus
|b 70
700 1 _ |a Lang, Fabian U
|b 71
700 1 _ |a Juckel, Georg
|b 72
700 1 _ |a Konrad, Carsten
|b 73
700 1 _ |0 0009-0007-5406-5319
|a Reimer, Jens
|b 74
700 1 _ |a Schmauß, Max
|b 75
700 1 _ |a Schmitt, Andrea
|b 76
700 1 _ |a Spitzer, Carsten
|b 77
700 1 _ |a von Hagen, Martin
|b 78
700 1 _ |0 P:(DE-2719)2811317
|a Wiltfang, Jens
|b 79
700 1 _ |a Zimmermann, Jörg
|b 80
700 1 _ |0 0000-0002-2917-5889
|a Andlauer, Till F M
|b 81
700 1 _ |0 P:(DE-2719)2000047
|a Fischer, Andre
|b 82
|u dzne
700 1 _ |a Bermpohl, Felix
|b 83
700 1 _ |0 0000-0003-4286-5830
|a Ritter, Philipp
|b 84
700 1 _ |a Matura, Silke
|b 85
700 1 _ |a Gryaznova, Anna
|b 86
700 1 _ |a Falkenberg, Irina
|b 87
700 1 _ |0 0000-0002-8386-6189
|a Yildiz, Cüneyt
|b 88
700 1 _ |a Kircher, Tilo
|b 89
700 1 _ |0 0000-0002-5942-2924
|a Schmidt, Julia
|b 90
700 1 _ |0 0000-0002-0908-7478
|a Koch, Marius
|b 91
700 1 _ |0 0000-0001-8629-0579
|a Gade, Kathrin
|b 92
700 1 _ |a Trost, Sarah
|b 93
700 1 _ |a Haussleiter, Ida S
|b 94
700 1 _ |a Lambert, Martin
|b 95
700 1 _ |a Rohenkohl, Anja C
|b 96
700 1 _ |a Kraft, Vivien
|b 97
700 1 _ |a Grof, Paul
|b 98
700 1 _ |a Hashimoto, Ryota
|b 99
700 1 _ |0 0000-0002-6621-3493
|a Hauser, Joanna
|b 100
700 1 _ |a Herms, Stefan
|b 101
700 1 _ |a Hoffmann, Per
|b 102
700 1 _ |a Jiménez, Esther
|b 103
700 1 _ |a Kahn, Jean-Pierre
|b 104
700 1 _ |a Kassem, Layla
|b 105
700 1 _ |0 0000-0003-0365-3587
|a Kuo, Po-Hsiu
|b 106
700 1 _ |a Kato, Tadafumi
|b 107
700 1 _ |a Kelsoe, John
|b 108
700 1 _ |0 0000-0003-3057-6150
|a Kittel-Schneider, Sarah
|b 109
700 1 _ |a Ferensztajn-Rochowiak, Ewa
|b 110
700 1 _ |a König, Barbara
|b 111
700 1 _ |0 0000-0002-8747-5070
|a Kusumi, Ichiro
|b 112
700 1 _ |a Laje, Gonzalo
|b 113
700 1 _ |0 0000-0002-4496-6451
|a Landén, Mikael
|b 114
700 1 _ |0 0000-0003-4987-2718
|a Lavebratt, Catharina
|b 115
700 1 _ |0 0000-0001-5473-3697
|a Leboyer, Marion
|b 116
700 1 _ |a Leckband, Susan G
|b 117
700 1 _ |0 0000-0002-8095-2305
|a Tortorella, Alfonso
|b 118
700 1 _ |a Manchia, Mirko
|b 119
700 1 _ |a Martinsson, Lina
|b 120
700 1 _ |0 0000-0001-6219-4945
|a McCarthy, Michael J
|b 121
700 1 _ |a McElroy, Susan
|b 122
700 1 _ |0 0000-0002-9516-9030
|a Colom, Francesc
|b 123
700 1 _ |0 0000-0003-1919-9649
|a Millischer, Vincent
|b 124
700 1 _ |a Mitjans, Marina
|b 125
700 1 _ |a Mondimore, Francis M
|b 126
700 1 _ |0 0000-0002-5287-3829
|a Monteleone, Palmiero
|b 127
700 1 _ |a Nievergelt, Caroline M
|b 128
700 1 _ |0 P:(DE-2719)9000400
|a Nöthen, Markus M.
|b 129
700 1 _ |0 0000-0001-9156-9654
|a Novák, Tomas
|b 130
700 1 _ |a O'Donovan, Claire
|b 131
700 1 _ |a Ozaki, Norio
|b 132
700 1 _ |a Pfennig, Andrea
|b 133
700 1 _ |0 0000-0002-9151-4319
|a Pisanu, Claudia
|b 134
700 1 _ |a Potash, James B
|b 135
700 1 _ |0 P:(DE-2719)9001554
|a Reif, Andreas
|b 136
700 1 _ |0 0000-0001-5964-4087
|a Reininghaus, Eva
|b 137
700 1 _ |0 0000-0001-8403-1418
|a Rouleau, Guy A
|b 138
700 1 _ |0 0000-0003-0577-0381
|a Rybakowski, Janusz K
|b 139
700 1 _ |0 0000-0001-5011-2922
|a Schalling, Martin
|b 140
700 1 _ |0 0000-0003-2967-9662
|a Schofield, Peter R
|b 141
700 1 _ |a Schweizer, Barbara W
|b 142
700 1 _ |0 0000-0002-6354-2662
|a Severino, Giovanni
|b 143
700 1 _ |a Shilling, Paul D
|b 144
700 1 _ |0 0000-0002-9663-6243
|a Shimoda, Katzutaka
|b 145
700 1 _ |a Simhandl, Christian
|b 146
700 1 _ |a Slaney, Claire M
|b 147
700 1 _ |0 0000-0001-7415-7607
|a Squassina, Alessio
|b 148
700 1 _ |a Stamm, Thomas
|b 149
700 1 _ |0 0000-0003-2712-3652
|a Stopkova, Pavla
|b 150
700 1 _ |a Maj, Mario
|b 151
700 1 _ |0 0000-0003-4075-2736
|a Turecki, Gustavo
|b 152
700 1 _ |0 0000-0002-0548-0053
|a Vieta, Eduard
|b 153
700 1 _ |a Veeh, Julia
|b 154
700 1 _ |0 0000-0002-1571-1468
|a Witt, Stephanie H
|b 155
700 1 _ |a Wright, Adam
|b 156
700 1 _ |0 0000-0001-8423-2623
|a Zandi, Peter P
|b 157
700 1 _ |a Mitchell, Philip B
|b 158
700 1 _ |a Bauer, Michael
|b 159
700 1 _ |0 0000-0001-9544-3944
|a Alda, Martin
|b 160
700 1 _ |0 0000-0002-5236-6149
|a Rietschel, Marcella
|b 161
700 1 _ |0 0000-0002-9469-305X
|a McMahon, Francis J
|b 162
700 1 _ |a Schulze, Thomas G
|b 163
700 1 _ |0 0000-0003-1640-5611
|a Clark, Scott R
|b 164
700 1 _ |a Baune, Bernhard T
|b 165
773 _ _ |0 PERI:(DE-600)1502531-7
|a 10.1038/s41380-023-02149-1
|g Vol. 28, no. 12, p. 5251 - 5261
|n 12
|p 5251 - 5261
|t Molecular psychiatry
|v 28
|x 1359-4184
|y 2023
856 4 _ |u https://pub.dzne.de/record/269348/files/DZNE-2024-00517%20SUP.docx
856 4 _ |u https://pub.dzne.de/record/269348/files/DZNE-2024-00517.pdf
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/269348/files/DZNE-2024-00517%20SUP.doc
856 4 _ |u https://pub.dzne.de/record/269348/files/DZNE-2024-00517%20SUP.odt
856 4 _ |u https://pub.dzne.de/record/269348/files/DZNE-2024-00517%20SUP.pdf
856 4 _ |u https://pub.dzne.de/record/269348/files/DZNE-2024-00517.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:pub.dzne.de:269348
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |0 I:(DE-HGF)0
|6 P:(DE-2719)2811701
|a External Institute
|b 49
|k Extern
910 1 _ |0 I:(DE-588)1065079516
|6 P:(DE-2719)2811317
|a Deutsches Zentrum für Neurodegenerative Erkrankungen
|b 79
|k DZNE
910 1 _ |0 I:(DE-588)1065079516
|6 P:(DE-2719)2000047
|a Deutsches Zentrum für Neurodegenerative Erkrankungen
|b 82
|k DZNE
913 1 _ |0 G:(DE-HGF)POF4-353
|1 G:(DE-HGF)POF4-350
|2 G:(DE-HGF)POF4-300
|3 G:(DE-HGF)POF4
|4 G:(DE-HGF)POF
|a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|v Clinical and Health Care Research
|x 0
913 1 _ |0 G:(DE-HGF)POF4-352
|1 G:(DE-HGF)POF4-350
|2 G:(DE-HGF)POF4-300
|3 G:(DE-HGF)POF4
|4 G:(DE-HGF)POF
|a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|v Disease Mechanisms
|x 1
914 1 _ |y 2023
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
|d 2023-08-25
915 _ _ |0 StatID:(DE-HGF)0160
|2 StatID
|a DBCoverage
|b Essential Science Indicators
|d 2023-08-25
915 _ _ |0 StatID:(DE-HGF)1050
|2 StatID
|a DBCoverage
|b BIOSIS Previews
|d 2023-08-25
915 _ _ |0 StatID:(DE-HGF)1190
|2 StatID
|a DBCoverage
|b Biological Abstracts
|d 2023-08-25
915 _ _ |0 StatID:(DE-HGF)0600
|2 StatID
|a DBCoverage
|b Ebsco Academic Search
|d 2023-08-25
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
|b MOL PSYCHIATR : 2022
|d 2023-08-25
915 _ _ |0 StatID:(DE-HGF)1030
|2 StatID
|a DBCoverage
|b Current Contents - Life Sciences
|d 2023-08-25
915 _ _ |0 StatID:(DE-HGF)9910
|2 StatID
|a IF >= 10
|b MOL PSYCHIATR : 2022
|d 2023-08-25
915 _ _ |0 StatID:(DE-HGF)0113
|2 StatID
|a WoS
|b Science Citation Index Expanded
|d 2023-08-25
915 _ _ |0 StatID:(DE-HGF)3002
|2 StatID
|a DEAL Springer
|d 2023-08-25
|w ger
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
|d 2023-08-25
915 _ _ |0 StatID:(DE-HGF)0510
|2 StatID
|a OpenAccess
915 _ _ |0 StatID:(DE-HGF)0030
|2 StatID
|a Peer Review
|b ASC
|d 2023-08-25
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
|d 2023-08-25
915 _ _ |0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
|a Creative Commons Attribution CC BY 4.0
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Clarivate Analytics Master Journal List
|d 2023-08-25
920 1 _ |0 I:(DE-2719)1410006
|k AG Wiltfang
|l Molecular biomarkers for predictive diagnostics of neurodegenerative diseases
|x 0
920 1 _ |0 I:(DE-2719)1410002
|k AG Fischer
|l Epigenetics and Systems Medicine in Neurodegenerative Diseases
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1410006
980 _ _ |a I:(DE-2719)1410002
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21